FundingWatcher
Home / Investors / Biotech investors / Biotech investors in Asia

Biotech investors in Asia

Updated 16 Nov 2026

Reset

Venture funds

34 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Qiming Venture Partners
Qiming Venture Partners invests in technology, consumer and healthcare companies at early and growth stages, with recent investments including Houmo.AI and AusperBio.
Shanghai, China
Health care, Artificial intelligence Seed, Early stage venture, Late stage venture 50% 11
2 Legend Capital
Legend Capital invests in China, with recent investments including Infinigence and Sinsegye.
Beijing, China
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 42% 7
3 ANRI
ANRI is a Japanese venture firm mainly investing in seed and early-stage startups, recently backing Craif and LAMP Japan.
Tokyo, Japan
Health care, Artificial intelligence Seed, Early stage venture, Late stage venture 26% 4
4 BioVenture
BioVenture offers early and growth stage investment, with recent investments including AusperBio and Degron Therapeutics.
Suzhou, China
Health care, Biotech Seed, Early stage venture, Late stage venture 33% 4
5 K2VC
K2VC invests in early stage technology startups, including Shexu Technology and Startorus Fusion.
Beijing, China
Commerce, Fintech Seed, Early stage venture 22% 4
6 Gaorong Capital
Gaorong Capital focuses on TMT investments including AI and frontier technologies, including BioGeometry and Raysolve.
Wangjing, China
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 29% 3
7 Global Brain Corporation
Global Brain Corporation invests from seed or early stage to pre-IPO, with recent investments including Newmo and Zafrens.
Tokyo, Japan
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 31% 3
8 Haitang Fund
Haitang Fund is a venture fund founded by Tianjin University alumni entrepreneurs, with recent investments in Zhonghe Gene and Xingsai Bio.
Nankai, China
Biotech, Health care Early stage venture 30% 3
9 IDG Capital
IDG Capital funds early- to growth-stage technology companies, with recent investments including Zero Zero Robotics and XPENG Robotics.
Beijing, China
Hardware, Fintech Seed, Early stage venture, Late stage venture 36% 3
10 Matrix Partners China
Matrix Partners China builds long-term relationships with entrepreneurs in China, with recent investments including Houmo.AI and Astribot.
Beijing, China
Artificial intelligence, Hardware Early stage venture 34% 3
11 Med-Fine Capital
Med-Fine Capital focuses on healthcare and bio-science, with recent investments including Artivila Therapeutics and Phrontline Biopharma.
Shanghai, China
Health care, Biotech Early stage venture 30% 3
12 Shenzhen Capital Group
Shenzhen Capital Group focuses on cultivating national industries and national brands, with recent investments including SAGE Intelligent and Chasing Innovation.
Nanshan, China
Hardware, Health care Seed, Early stage venture, Late stage venture 40% 3
13 Shunwei Capital
Shunwei Capital focuses on China's internet industry at early to mid stages, with recent companies including SAGE Intelligent and Hooke Instruments.
Beijing, China
Hardware, Commerce Seed, Early stage venture, Late stage venture 31% 3
14 BioTrack Capital
BioTrack Capital invests in life sciences, healthcare technology and biotechnology, with recent companies including Yuce Biotechnology and Rigen Biotech.
Shanghai, China
Health care, Biotech Seed, Early stage venture, Late stage venture 33% 2
15 Boyuan Capital
Boyuan Capital operates as an investment platform, with recent companies Yuce Biotechnology and Rigen Biotech.
Shanghai, China
Health care, Biotech Late stage venture 38% 2
16 Chengdu Science and Technology Venture Capital
Chengdu Science and Technology Venture Capital is a venture firm with recent companies including Kunteng Tech, QL Biopharma and New Radiomedicine Technology.
Chengdu, China
Biotech, Health care Early stage venture, Late stage venture 36% 2
17 Coral Capital
Coral Capital invests at the seed stage with a full-service approach, with recent companies including Facilo, Dioseve and Cosomil.
Tokyo, Japan
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 29% 2
18 Fuho Capital
Fuho Capital is an equity investment fund management company with recent investments in Novamab and Leman Biotech.
Haidian, China
Biotech, Health care Seed, Early stage venture, Late stage venture 24% 2
19 Green Pine Capital Partners
Green Pine Capital Partners is a venture firm whose recent companies include RealAI and MindRank AI.
Shenzhen, China
Hardware, Artificial intelligence Seed, Early stage venture, Late stage venture 32% 2
20 Kaitai Capital
Kaitai Capital is a professional investment management organization, with recent companies including Xihu Xinchen and Bivision.
Hangzhou, China
Artificial intelligence, Biotech Early stage venture 30% 2
21 Korea Investment Partners
Korea Investment Partners is a venture and private equity firm, with recent companies HITS and LabInCube.
Seoul, South Korea
Artificial intelligence, Commerce Early stage venture 25% 2
22 Lenovo Capital and Incubator Group (LCIG)
Lenovo Capital and Incubator Group operates as an accelerator and venture firm, with recent investments including Elite Robots and Aibo Medical Robot.
Beijing, China
Hardware, Artificial intelligence Seed, Early stage venture, Late stage venture 24% 2
23 Linear Capital
Linear Capital invests in data application projects, with recent companies SynMetaBio, Dishi Medical and ReaVis.
Shanghai, China
Artificial intelligence, Hardware Seed, Early stage venture, Late stage venture 31% 2
24 5Y Capital
5Y Capital makes early-stage venture investments, with recent investments in Etern and CellCentric.
Xuhui, China
Artificial intelligence, Commerce Seed, Early stage venture, Late stage venture 31% 2
25 Northern Light Venture Capital
Northern Light Venture Capital funds early- and growth-stage tech and consumer service companies, with recent investments including HemaCell and Picky.
Beijing, China
Hardware, Artificial intelligence Seed, Early stage venture, Late stage venture 24% 2
26 Oriza Holdings
Oriza Holdings provides equity and debt financing to Chinese companies, with recent backings including Listenai and TuringQ.
Suzhou, China
Hardware, Artificial intelligence Seed, Early stage venture, Late stage venture 25% 2
27 SDIC Venture Capital
SDIC Venture Capital manages four funds for semiconductor and pharmaceutical companies, including Bangxin Semiconductor and Ouye Semiconductor.
Xicheng, China
Hardware, Health care Seed, Early stage venture, Late stage venture 54% 2
28 Sherpa Healthcare Partners
Sherpa Healthcare Partners focuses on pharmaceutical and biotech companies, with recent investments in MindRank AI and UniXell Biotechnology.
Beijing, China
Health care, Biotech Seed, Early stage venture, Late stage venture 29% 2
29 Spiral Capital
Spiral Capital is a venture capital fund, with recent companies including AZUL Energy and Mozu.
Tokyo, Japan
Artificial intelligence, Biotech Early stage venture, Late stage venture 30% 2
30 STIC Ventures
STIC Ventures invests in small and mid-sized companies with core technologies and new business models, such as HITS and Apollon.
Seoul, South Korea
Artificial intelligence, Biotech Seed, Early stage venture, Late stage venture 7% 2
31 SZHTI Group
SZHTI Group provides asset management and financing services, including investments tied to Elegoo and SpinQ Technology.
Shenzhen, China
Hardware, Biotech Early stage venture 30% 2
32 Tiantu Capital
Tiantu Capital is a venture capital association, with recent investments in Xellar Biosystems and Leman Biotech.
Shenzhen, China
Commerce, Artificial intelligence Seed, Early stage venture 52% 2
33 Wuxi Capital
Wuxi Capital is a financial investment platform backing companies such as Kai Medtech and Sandstone.
Wuxi Shi, China
Hardware, Health care Seed 34% 2
34 Zhengxuan Investment
Zhengxuan Investment invests in high-tech enterprises, with recent companies Yuce Biotechnology and Xellar Biosystems.
Shenzhen, China
Hardware, Artificial intelligence Seed, Early stage venture 49% 2

Table 1. Biotech investors in Asia: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in Asia
One-time CSV
  • 214 firms, 209 with a website
  • 141 firm email addresses
  • 153 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-asia.csv214 rows × 15 columns
InvestorTypeLocationEmailPhone
Qiming Venture PartnersVenture capital firmShanghai, China•••@qimingvc.com(+86) •••
TIPS ProgramStartup incubatorGangneung, South Korea•••@kban.or.kr+82 2-•••
Legend CapitalVenture capital firmBeijing, China•••@legendcapital.com.cn
Lilly Asia VenturesVenture capital firmShanghai, China•••@lillyasiaventures.com+86 21•••
Turkey Development FundFund of fundsUmraniye, Turkey•••@kalkinma.com.tr(+90) •••
Matrix Partners ChinaVenture capital firmBeijing, China•••@matrixpartners.com.cn+86-10•••
AntlerVenture capital firmSingapore•••@antler.co
BioVentureVenture capital firmSuzhou, China•••@bioventure.com.cn+86512•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

214
Investors
141
With email
153
With phone
186
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in Asia

30 of 214, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Qiming Venture Partners Venture capital firm Shanghai, China Health care, Artificial intelligence Houmo.AI, Infinigence, AusperBio 21 1,106 555 104 •••@qimingvc.com (+86) ••• In the CSV
2 TIPS Program Startup incubator Gangneung, South Korea Artificial intelligence, Hardware Caredoc, Switchwon, Apollon 24 1,922 1,120 62 •••@kban.or.kr +82 2-••• In the CSV
3 Legend Capital Venture capital firm Beijing, China Artificial intelligence, Hardware Infinigence, Sinsegye, Diyingjia Technology 18 569 240 60 •••@legendcapital.com.cn In the CSV
4 Lilly Asia Ventures Venture capital firm Shanghai, China Health care, Biotech Precede Biosciences, Akura Medical 2 237 68 49 •••@lillyasiaventures.com +86 21••• In the CSV
5 Turkey Development Fund Fund of funds, Private equity firm Umraniye, Turkey Artificial intelligence, Hardware Viseur AI, Parabellum Systems 2 163 110 0 •••@kalkinma.com.tr (+90) ••• In the CSV
6 Matrix Partners China Venture capital firm Beijing, China Artificial intelligence, Hardware Houmo.AI, Astribot, SemiDrive 14 793 271 59 •••@matrixpartners.com.cn +86-10••• In the CSV
7 Antler Venture capital firm Singapore Artificial intelligence, Fintech Futuriza, AirDodge AS, Satlyt 44 2,309 933 24 •••@antler.co In the CSV
8 BioVenture Venture capital firm Suzhou, China Health care, Biotech AusperBio, Degron Therapeutics, AccuPulse 5 182 60 13 •••@bioventure.com.cn +86512•••
9 Kaitai Capital Venture capital firm Hangzhou, China Artificial intelligence, Biotech Xihu Xinchen, Bivision, Levinthal 3 149 44 8 +86 57••• In the CSV
10 Hillhouse Investment Angel group, Private equity firm Singapore Artificial intelligence, Hardware FAIRINO, Suzhou Xizhi Technology, Etern 10 465 200 86 •••@hillhouseinvestment.com +91877••• In the CSV
11 OurCrowd Venture capital firm Jerusalem, Israel Hardware, Artificial intelligence Scentian Bio 1 392 60 64 •••@ourcrowd.com In the CSV
12 CDH Investments Private equity firm Kowloon City, Hong Kong Health care, Hardware Aibo Medical Robot, LaiHua, Frebang 9 345 148 44 •••@gmail.com +86 10••• In the CSV
13 Global Brain Corporation Venture capital firm Tokyo, Japan Artificial intelligence, Hardware Newmo, Zafrens, Cornelis Networks 16 804 246 119 •••@globalbrains.com In the CSV
14 Shenzhen Capital Group Venture capital firm Nanshan, China Hardware, Health care SAGE Intelligent, Chasing Innovation, Kai Medtech 16 794 316 102 •••@szvc.com.cn 0755-8••• In the CSV
15 Northern Light Venture Capital Venture capital firm Beijing, China Hardware, Artificial intelligence Nutshell Therapeutics, HemaCell, Picky 5 458 110 66 •••@nlightvc.com 650-58••• In the CSV
16 Gaorong Capital Venture capital firm Wangjing, China Artificial intelligence, Hardware BioGeometry, Shexu Technology, Raysolve 9 358 103 29 010-84••• In the CSV
17 Mirae Asset Venture Investment Venture capital firm Seongnam, South Korea Commerce, Health care KreditBee, BreezeBio 2 311 41 42 •••@miraasset.com +82 02••• In the CSV
18 CMB International Capital Corporation Investment bank Central, Hong Kong Hardware, Biotech HemaCell, Zhide New Energy, Alpha Better 3 138 57 20 852 39••• In the CSV
19 IDG Capital Private equity firm, Venture capital firm Beijing, China Hardware, Fintech Zero Zero Robotics, XPENG Robotics, LaiHua 13 1,565 567 183 •••@idgcapital.com +86 10••• In the CSV
20 Temasek Private equity firm Singapore Hardware, Artificial intelligence Rize, Nearfield Instruments, Black Lake Technologies 3 658 295 167 •••@temasek.com.sg +65 68••• In the CSV
21 KB Investment Private equity firm, Venture capital firm Seoul, South Korea Artificial intelligence, Hardware Apollon, Turing, Liner 11 423 78 33 +82 25••• In the CSV
22 K2VC Angel group, Venture capital firm Beijing, China Commerce, Fintech Renshuo Solar, Shexu Technology, Aureka Biotechnologies 9 337 73 9 •••@k2vc.com +86 10••• In the CSV
23 Puhua Capital Venture capital firm Hangzhou, China Hardware, Health care Yuce Biotechnology, LaiHua, Garen Semiconductor 6 269 88 14 •••@puhuacapital.com +571 8••• In the CSV
24 Korea Investment Partners Private equity firm, Venture capital firm Seoul, South Korea Artificial intelligence, Commerce HITS, NEW ID, LabInCube 5 523 129 69 In the CSV
25 Brinc Startup accelerator Central, Hong Kong Artificial intelligence, Health care Omni, EyeROV, Botsync 4 378 123 9 •••@brinc.io +852 3••• In the CSV
26 Horizons Ventures Venture capital firm Hong Kong Artificial intelligence, Hardware Cauldron Ferm 1 348 148 53 (773) ••• In the CSV
27 5Y Capital Venture capital firm Xuhui, China Artificial intelligence, Commerce Etern, CellCentric, BOTINKIT 4 345 108 28 +86 20••• In the CSV
28 Frees Fund Venture capital firm Beijing, China Artificial intelligence, Hardware Vibronix, Aeroband, Calterah 5 233 63 12 •••@freesvc.com In the CSV
29 EDBI Venture capital firm Singapore Hardware, Health care Leo Cancer Care, Aspen Neuroscience 2 210 43 57 •••@edbi.com (656)8••• In the CSV
30 BioTrack Capital Venture capital firm Shanghai, China Health care, Biotech Yuce Biotechnology, Shenluo Medical, Rigen Biotech 3 85 28 5 +86-02•••

Table 2. Biotech investors in Asia: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 214.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Antler Singapore 44 831 Futuriza, AirDodge AS, Satlyt
2 Lenovo Capital and Incubator Group (LCIG) Beijing, China 27 99 Micronano Core, Elite Robots, Aibo Medical Robot
3 TIPS Program Gangneung, South Korea 24 325 Caredoc, Switchwon, Apollon
4 Qiming Venture Partners Shanghai, China 21 154 Houmo.AI, Infinigence, AusperBio
5 Legend Capital Beijing, China 18 103 Infinigence, Sinsegye, Diyingjia Technology
6 CAS Star Xian, China 17 58 Matrixtime Robotics, Renshuo Solar, YUSUR Technology
7 Global Brain Corporation Tokyo, Japan 16 171 Newmo, Zafrens, Cornelis Networks
8 Shenzhen Capital Group Nanshan, China 16 166 SAGE Intelligent, Chasing Innovation, Kai Medtech
9 Fortune Venture Capital Shenzhen, China 15 79 Global Technology, Zhongke Ruijian, Xunjie Guangyuan
10 Mitsubishi UFJ Capital Tokyo, Japan 15 124 Spectronix, Astra Food Plan, QibiTech
11 Mizuho Capital Tokyo, Japan 14 97 Newmo, QibiTech, Paytner
12 Matrix Partners China Beijing, China 14 186 Houmo.AI, Astribot, SemiDrive
13 IDG Capital Beijing, China 13 257 Zero Zero Robotics, XPENG Robotics, LaiHua
14 Shunwei Capital Beijing, China 12 125 SAGE Intelligent, Hooke Instruments, Zongwei Automation
15 SMBC Venture Capital Tokyo, Japan 11 115 Newmo, Indent, Spectronix

Table 3. Biotech investors in Asia: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Newmo Newmo develops a ride-sharing platform that provides transportation to local communities and consumers. Software Minato, Japan Series B $131.5M 2026-11-09 $255.1M Global Brain Corporation, SMBC Venture Capital, Mizuho Capital +1 51 to 100 2024
Huasaiboman Medical Cell Biology Huasaiboman Medical Cell Biology provides new cell therapy technologies and solutions as a biotechnology company. Biotech Qingdao Shi, China Series B $30.0M 2026-11-09 $30.0M ASBV 11 to 50 2019
Tushen Zhihe Tushen Zhihe provides artificial intelligence protein design services. Artificial intelligence Minhang, China Seed $1.4M 2026-11-09 $1.5M Wuxi Capital 11 to 50 2023
Bangxin Semiconductor Bangxin Semiconductor delivers cost-effective semiconductor equipment. Hardware Shanghai, China Series B $90.0M 2026-11-05 $90.0M SDIC Venture Capital 2020
altM altM is an alternate materials company. Biotech Bangalore, India Series A $10.3M 2026-11-05 $13.8M Omnivore 11 to 50 2022
Pliant Pliant provides modular, API-first B2B payment solutions for businesses. Fintech Berlin, Germany Series C $80.0M 2026-11-04 $305.1M SBI Investment 251 to 500 2020
Moffett AI Moffett AI designs AI chips and provides terminal and cloud AI chip acceleration solutions. Artificial intelligence Los Altos, United States Series C $150.0M 2026-11-03 $322.8M ZhenFund, Qianhai Fund of Funds 11 to 50 2018
Global Technology Global Technology supplies automotive intelligent driving systems. Hardware Mumbai, India Series C $90.0M 2026-11-03 $153.9M CICC, Fortune Venture Capital 101 to 250 2001
Zhongke Ruijian Zhongke Ruijian provides an AI-based counterfeit detection platform for digital content security. Artificial intelligence Hangzhou, China Series A $14.0M 2026-11-03 $14.0M Fortune Venture Capital 11 to 50 2020
Zafrens Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. Biotech San Diego, United States Series A $6.0M 2026-11-03 $35.0M Global Brain Corporation 11 to 50 2022

Table 4. Biotech investors in Asia: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 4,194 69%
Artificial intelligence 1,433 24%
Hardware 1,259 21%
Health care 880 15%
Fintech 783 13%
Commerce 589 10%
Biotech 458 8%
Education 333 5%
Cybersecurity 182 3%
Energy 166 3%

Table 5. Biotech investors in Asia: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Biotech investors in Asia by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesInvestorsShare
China 124 58%
South Korea 23 11%
Japan 18 8%
Singapore 13 6%
Israel 11 5%
India 11 5%
Hong Kong 7 3%
Turkey 3 1%
Taiwan 2 1%
United Arab Emirates 2 1%

Table 7. Biotech investors in Asia by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Beijing 42 20%
Shanghai 24 11%
Shenzhen 18 8%
Seoul 16 7%
Singapore 13 6%
Tokyo 13 6%
Mumbai 7 3%
Hangzhou 5 2%
Suzhou 4 2%
Hong Kong 4 2%
Tel Aviv 4 2%
Herzliya 3 1%

Table 8. Biotech investors in Asia by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 11 6%
2010s 102 51%
2000s 50 25%
1990s 25 12%
1980s 7 4%
1970s 4 2%

Table 9. Biotech investors in Asia by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in Asia are on the list?
214, in the file dated 16 November 2026. 186 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
141 of the 214 carry an email address in the download and 153 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 214 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 214 rows, 141 firm email addresses and 153 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 79 of the 141 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in Asia: 214 rows, CSV, $29 one-time.

At once: the CSV with 214 rows, 141 firm email addresses and 153 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 79 of the 141 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech investors by city in Asia

Investor types in Asia

Other portfolio sectors in Asia

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 214 biotech investors in Asia, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/asia/